Hematology

Research Frontiers in Lymphomas Associated BRAF and MAP2K1 Mutations

Investigation of BRAF V600E and MEK1/2 mutations in Hodgkin and non-Hodgkin lymphomas, targeted therapy response and resistance.

All Hematology PhD categories